Short-term outcome of infants presenting to pediatric intensive care unit with new cardiac diagnoses

Congenit Heart Dis. 2010 Sep-Oct;5(5):444-9. doi: 10.1111/j.1747-0803.2010.00430.x.

Abstract

Aims: To outline the etiology, clinical course, short-term survival to discharge and neurological outcome of infants (<1 yr) with new cardiac diagnoses presenting to a pediatric intensive care (PICU) unit with acute cardiac compromise.

Methods: Retrospective search of a computerized database and medical case notes for all acute cardiac admissions to PICU from June 2001 to 2006. Pre-existing hospital-based patients with new cardiac diagnoses were excluded.

Results: Seventy patients were identified, 38 (54%) of whom were male. There were six main subgroups: obstructive left heart lesions (n= 20), transposition of the great arteries (TGA) (n= 9), total anomalous pulmonary venous drainage (TAPVD) (n= 7), dilated cardiomyopathy (n= 11), arrhythmia (n= 12), and others (n= 11). Fifty-nine patients (84%) were external referrals to our center. The median age at presentation was 13.5 days (0-272) with median duration of symptoms of 1 day (0-21). The median base deficit at presentation was -7.6 mEq/L (-43 to +4.2). Fifty-three patients (76%) required respiratory support with a median duration of ventilation of 4 days (1-49). Fifty-six patients (80%) required inotropic support. The median PICU stay was 7 days (1-64) with a median total hospital stay of 16 days (1-71). Six patients (9%) died prior to discharge. Of the survivors 7 (11%) had seizure activity or evolving clinical neurological abnormalities.

Conclusions: Cardiovascular compromise due to previously unrecognized congenital or acquired heart disease is associated with clinically significant morbidity and mortality. Longer term follow-up is required to evaluate the initial effect of poor cardiac output and hypoxia on long-term neurodevelopmental outcome.

MeSH terms

  • Cardiotonic Agents / therapeutic use
  • Child Development
  • Delayed Diagnosis
  • England
  • Female
  • Heart Diseases / complications
  • Heart Diseases / diagnosis*
  • Heart Diseases / mortality
  • Heart Diseases / physiopathology
  • Heart Diseases / therapy*
  • Hospital Mortality
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units, Pediatric* / statistics & numerical data
  • Length of Stay
  • Male
  • Nervous System / growth & development
  • Outcome and Process Assessment, Health Care* / statistics & numerical data
  • Patient Discharge
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Seizures / etiology
  • Seizures / physiopathology
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiotonic Agents